ALBUQUERQUE – January 5, 2021 – Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) is now enrolling patients in the iCLAS™ U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Persistent Atrial Fibrillation. The iCLAS catheter device cuts hours off an ablation procedure, leading to a better outcome and faster recovery time for the patient. HHNM is the only site in New Mexico offering this advanced procedure, performed by New Mexico Heart Institute/Lovelace Medical Group electrophysiologists.